Nova vax 904

Select a filter

Indications for Use:

For vaccination against Type A avian influenza viruses (subtype H9N2) and Newcastle disease virus (NDV4).

In broiler, layer, breeder, grandparent chicken flocks and turkeys.

Product Description:

Nova Rad Vax 904 vaccine is produced based on the viruses currently circulating in Iran and the Middle East region and shows the highest antigenic similarity to the pathogenic viruses prevalent in this area. The product contains a minimum haemagglutinating activity of 10 log₂ HAU of inactivated Newcastle disease virus (NDV strain V4) and 9 log₂ HAU of inactivated avian influenza virus (subtype H9N2). Following vaccination, the vaccine is capable of inducing adequate antibody responses against Newcastle disease virus and avian influenza virus and provides active immunity against Newcastle disease and Type A avian influenza (H9N2).

Nova Rad Vax 904 is formulated with an oil‑based adjuvant, acts as a strong inducer of antibody production and is stable, low‑viscosity, and easy to administer.

Dosage and Administration:

Chicks up to 14 days of age: administer 0.25 ml subcutaneously in the back of the neck.

Chicks from 3 weeks of age onwards: Administer 0.5 ml subcutaneously in the back of the neck or intramuscularly in the breast muscle.

Breeder and commercial layer flocks: Two vaccinations are recommended at an interval of 4–6 weeks.

If necessary, a booster dose should be administered 6 months after the second vaccination.

Precautions before use:

The vaccination programme must be completed four weeks before the onset of lay.

Before use, allow the contents of the bottle to reach room temperature and shake thoroughly.

Packaging and Storage:

Packaging: 500 mL bottles (2500 doses).

Storage temperature: Store at 2–8°C (protect from freezing).

Warning:

In case of accidental self‑injection, seek medical attention immediately.